AKT1 and liver cancer: In case of liver cancer cells, luteolin has been found to inhibit cell migration and invasion by reducing the phosphorylation of c-Met (hepatocyte growth factor receptor), as well as modulating the MAPK and PI3K-AKT pathways [40].